Press release
Spinal Muscular Atrophy Market to Record Sturdy Growth by 2023
Cytokinetics, Inc., a biopharmaceutical company in partnership with a Japanese firm Astellas Pharma, is working to on developing Tirasemtiv, which is a drug in its phase II clinical trials, being studied for the treatment of spinal muscular atrophy. Besides, after a long wait, a medicine developed by Biogen, SPINRAZA was approved last year by the U.S. Food and Drug Administration that was working to come up with a treatment for spinal muscular degeneration in infants and adults.
On the basis of geographical segmentation, North American region is gaining high traction owing to the advancement in the technology. Asia-Pacific region is anticipated to dominate the other regions with a strong CAGR in the coming years.
Request to View Sample of Report -
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=7187
SMA Drugs Market to Benefit Owing to Increased Government Initiatives
The rise in the population suffering from spinal muscular atrophy is one of the key factors leading to high demand for SMA drugs in the market. For now, there is no proper treatment for the disease. The only treatment available are on the basis of the initial symptoms and not the actual medical cause. As the region such as Europe, and the U.S. have declared the drugs for the disease as orphan, the government initiatives have increased in this direction. Moreover the other firms are also encouraged to work towards developing an efficient treatment for spinal muscular atrophy. Majority of the pipeline drugs are given various financial relaxations, for example preference in new drug application review and tax benefits in clinical researches are offered to drugs that are still in the development phase. These discounts are in turn are proving to be very advantageous for these pipeline drugs, allowing them to be tested at a faster pace.
Another major driving force for the growth in the market is surge in number of carriers that have damaged spinal muscular atrophy genes. These factors are propelling the pharmaceuticals and healthcare firms to develop a cost-effective and efficient solution for the disease, along with working towards spreading awareness among the masses.
Request to View Brochure of Report -
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=7187
Market Growth to Decline Due to Unavailability of Insufficient Treatment Options
With the rise in number of cases suffering from spinal muscular atrophy, several government departments and medical institutes are working to keep the disease under control. However, the studies and the development of drugs are irrespective of the age group of people suffering from it. This factor is likely to reduce efficiency of the treatment along with the improper diagnosis of the disease. This scenario also makes it difficult for the disease to be gauged with accuracy. Owing to these situations, the global market is estimated to decline, with the reduced rate of development.
View Report -
https://www.transparencymarketresearch.com/spinal-muscular-atrophy-market.html
About Us
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Spinal Muscular Atrophy Market to Record Sturdy Growth by 2023 here
News-ID: 1092971 • Views: …
More Releases from Transparency Market Research
Handheld Marijuana Vaporizer Market Key Drivers, Market Research, and Insights f …
The global handheld marijuana vaporizer market has witnessed remarkable growth in recent years, attributed to the increasing acceptance of medicinal marijuana and the demand for convenient and discreet consumption methods. Valued at US$ 5 billion in 2021, the market is projected to surge at a CAGR of 13.4% to reach US$ 15.9 billion by 2031. This article delves into the factors driving this growth, the evolving market landscape, and the…
Disinfectant Wipes Market Forecast 2020-2030 - Market Size, Drivers, Trends, And …
The COVID-19 pandemic has precipitated a remarkable surge in the demand for disinfectant products, with a notable emphasis on disinfectant wipes as an essential tool in maintaining hygiene and preventing the spread of pathogens. This research report delves into the multifaceted landscape of the disinfectant wipes market, elucidating key trends, drivers, and innovations shaping the industry.
𝐆𝐞𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐭𝐡𝐢𝐬 𝐫𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐫𝐞𝐩𝐨𝐫𝐭 @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=70359
Key Players and Market Developments
Key players…
Tissue Banking Market is Expected to Reach US$ 2,903.3 Million to 2026| TMR Stud …
The global 𝐭𝐢𝐬𝐬𝐮𝐞 𝐛𝐚𝐧𝐤𝐢𝐧𝐠 𝐦𝐚𝐫𝐤𝐞𝐭 reached a value of US$ 1,056.4 million in 2017 and is projected to nearly triple to US$ 2,903.3 million by 2026, with a robust Compound Annual Growth Rate (CAGR) of approximately 12.0% from 2018 to 2026. Factors such as increasing awareness about tissue donation, technological advancements, and a growing target patient population are anticipated to propel market growth during this period.
Moreover, the market is expected…
Vascular Closure Devices Market to reach US$ 1 Billion by 2027: TMR Study
This report by Transparency Market Research, Inc. assesses the present state and future growth potential of the global 𝐯𝐚𝐬𝐜𝐮𝐥𝐚𝐫 𝐜𝐥𝐨𝐬𝐮𝐫𝐞 𝐝𝐞𝐯𝐢𝐜𝐞𝐬 𝐦𝐚𝐫𝐤𝐞𝐭. It features a comprehensive executive summary, offering insights into various segments of the market. Additionally, the report provides detailed analysis and data on product, access type, application, end user, and regional segments within the global market.
Vascular closure devices is estimated to reach a value of ~US$ 1 Bn…
More Releases for Spinal
Spinal Non-Fusion
Spinal implants are devices used for the treatment of spinal disorders such as disproportion and instability of spine. Spine surgical devices are broadly classified into fusion and non-fusion devices. Fusion devices heals by providing immediate and rigid immobilization, and non-fusion devices treats by replacing pro-inflammatory tissues, restoring spinal alignment, and decompressing neural elements while preserving functional movements rather than obliterating it. The advantages such as prolonged recuperation time, bone graft…
Different Approaches to Spinal Fusion Market And Control Spinal Deformity Develo …
Spinal fusion is surgery to permanently join together two or more bones in the spine so there is no movement between them. For patients who require spinal fusion surgery to treat lumbar degenerative disc disease (DDD), spinal fusion device is a treatment option.
Spinal fusion has been used for many years to treat many painful conditions in the lumbar (lower) spine. Over the past decade, there has been dramatic improvement in…
Spinal Cord Compression-Spinal Stenosis Market Progresses for Huge Profits by 20 …
The Global Spinal Cord Compression-Spinal Stenosis Market is expected to reach $ 8.5 billion by the end of 2023, this market is projected to growing at a CAGR of ~ 11.5 % during 2017-2023.
Spinal stenosis is the abnormal narrowing of spinal canal causing it to restrict, which may result in a neurological deficit due to interference with neurological fibres. The associated symptoms include pain, numbness, loss of motor control etc.…
Spinal Cord Compression-Spinal Stenosis Market Report: Industry Manufacturers An …
Marketresearchfuture.com includes Global Spinal Cord Compression-Spinal Stenosis Market by indications, by diagnosis, by end users - Global Forecast till 2023 is new report.
Spinal cord compression is the second most frequent neurologic complication of cancer. Only in the United States, each year nearly 20,000 people with cancer develop spinal cord compression; this affected population represents 5% to 10% of the general cancer population.
Request Sample copy of Spinal cord compression-spinal stenosis…
Spinal Trauma Devices Market: Spinal Trauma Devices Sales to Surge Rapidly in Re …
The global spinal trauma devices market is dynamic and highly competitive. Only a couple of companies account for a substantial share in the market, thus lending it an oligopolistic vendor landscape. The market is largely dominated by DePuy Synthes, Medtronic, NuVasive, Inc., Stryker Corporation, and Globus Medical, Inc. The cumulative share of these companies added up to 79.1% in 2014, says Transparency Market Research (TMR) in a new report.
As…
Spinal Implants and Spinal Devices Market Analysis, Development and Demand Forec …
The global spinal implants and spinal devices market is growing, due to increasing demand for minimally invasive surgeries, increasing number of hospitals and surgical centers, and commercial applications in areas, such as nucleus arthroplasty, stem cell technology and artificial disk replacement. The spinal fusion and fixation technology dominates the market and the non-fusion/ motion preservation technology segment is expected to grow with the fastest rate during the forecast period, due…
